Supporting Future Clinical Bioinformaticians - Part 1
Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose…
September 20, 2023
3 min
#nextflow 43
EPI2ME 23.09-01 Release![Matt Parker]()
Dear Nanopore Community, The Customer Workflows team hope that our users in the northern hemisphere…
September 06, 2023
2 min
EPI2ME 23.08-01 Release![Chris Wright]()
Dear Nanopore Community, We're please to bring a small set of updates to our Nextflow workflows…
August 10, 2023
1 min
EPI2ME 23.07-01 Release![Chris Wright]()
Dear Nanopore Community, We’re pleased to bring user experience updates to our EPI2ME desktop…
July 26, 2023
2 min
Targeted BRCA Gene Analysis with Oxford Nanopore![Matt Parker]()
Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose…
June 19, 2023
4 min
EPI2ME 23.06-01 Release![Stephen Rudd]()
Dear Nanopore Community, With this first June release, we are delighted to update our EPI2ME…
June 14, 2023
1 min
Page 1 of 8
Information
© 2020 - 2023 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.